9ILB
 
 | | HUMAN INTERLEUKIN-1 BETA | | Descriptor: | PROTEIN (HUMAN INTERLEUKIN-1 BETA) | | Authors: | Yu, B, Blaber, M, Gronenborn, A.M, Clore, G.M, Caspar, D.L.D. | | Deposit date: | 1998-10-22 | | Release date: | 1999-01-06 | | Last modified: | 2023-09-20 | | Method: | X-RAY DIFFRACTION (2.28 Å) | | Cite: | Disordered water within a hydrophobic protein cavity visualized by x-ray crystallography.
Proc.Natl.Acad.Sci.USA, 96, 1999
|
|
1S0L
 | |
6Y8M
 | |
4X3A
 | |
31BI
 | |
5I1B
 | |
5MVZ
 | | Fab 4AB007 bound to Interleukin-1-beta | | Descriptor: | Fab 4AB007 H-chain, Fab 4AB007 L-chain, GLYCEROL, ... | | Authors: | Stark, W, Seibert, V. | | Deposit date: | 2017-01-17 | | Release date: | 2017-02-15 | | Last modified: | 2019-02-20 | | Method: | X-RAY DIFFRACTION (2.15 Å) | | Cite: | Structure of a novel, fully Human Fab binding to Interleukin 1-beta.
To Be Published
|
|
5UC6
 | |
8C3U
 | | Crystal Structure of human IL-1beta in complex with a low molecular weight antagonist | | Descriptor: | (S)-4'-hydroxy-3'-(6-methyl-2-oxo-3-(1H-pyrazol-4-yl)indolin-3-yl)-[1,1'-biphenyl]-2,4-dicarboxylic acid, Interleukin-1 beta | | Authors: | Rondeau, J.-M, Lehmann, S, Koch, E. | | Deposit date: | 2022-12-28 | | Release date: | 2023-09-13 | | Last modified: | 2024-03-27 | | Method: | X-RAY DIFFRACTION (1.945 Å) | | Cite: | Discovery of a selective and biologically active low-molecular weight antagonist of human interleukin-1 beta.
Nat Commun, 14, 2023
|
|
2NVH
 | |
7I1B
 | |
6Y8I
 | |
21BI
 | |
5HN1
 | | Crystal structure of Interleukin-37 | | Descriptor: | Interleukin-37, SULFATE ION | | Authors: | Ellisdon, A.M, Nold-Petry, C.A, Nold, M.F, Whisstock, J.C. | | Deposit date: | 2016-01-17 | | Release date: | 2017-02-22 | | Last modified: | 2023-09-27 | | Method: | X-RAY DIFFRACTION (2.25 Å) | | Cite: | Homodimerization attenuates the anti-inflammatory activity of interleukin-37.
Sci Immunol, 2, 2017
|
|
7Z4T
 | | AAL160 FAB IN COMPLEX WITH HUMAN INTERLEUKIN-1 BETA | | Descriptor: | AAL160 Fab heavy-chain, AAL160 light-chain, Interleukin-1 beta | | Authors: | Rondeau, J.M, Lehmann, S. | | Deposit date: | 2022-03-04 | | Release date: | 2023-02-08 | | Last modified: | 2024-10-16 | | Method: | X-RAY DIFFRACTION (3.3 Å) | | Cite: | "Redirecting an anti-IL-1 beta antibody to bind a new, unrelated and computationally predicted epitope on hIL-17A".
Commun Biol, 6, 2023
|
|
3LTQ
 | |
6NCU
 | | Interleukin-37 residues 53-206- dimer | | Descriptor: | Interleukin-37 | | Authors: | Eisenmesser, E.Z. | | Deposit date: | 2018-12-12 | | Release date: | 2019-03-13 | | Last modified: | 2024-04-24 | | Method: | X-RAY DIFFRACTION (3.5 Å) | | Cite: | Interleukin-37 monomer is the active form for reducing innate immunity.
Proc. Natl. Acad. Sci. U.S.A., 116, 2019
|
|
4P0J
 | | Crystal Structure of Loop-Swapped Interleukin-36Ra | | Descriptor: | Interleukin-36 receptor antagonist/Interleukin-36 gamma chimera protein | | Authors: | Guenther, S, Sundberg, E.J. | | Deposit date: | 2014-02-21 | | Release date: | 2014-06-25 | | Last modified: | 2023-09-27 | | Method: | X-RAY DIFFRACTION (2.298 Å) | | Cite: | Molecular Determinants of Agonist and Antagonist Signaling through the IL-36 Receptor.
J Immunol., 193, 2014
|
|
8RYK
 | |
8RZB
 | | IL-1beta in complex with covalent DEL hit | | Descriptor: | 8-[4-methyl-3-(trifluoromethyl)phenyl]-2-[[(7S)-7-(2-morpholin-4-ylethylcarbamoyl)-4-(phenylsulfonyl)-1,4-diazepan-1-yl]carbonyl]imidazo[1,2-a]pyridine-6-carboxylic acid, Interleukin-1 beta | | Authors: | Rondeau, J.-M, Lehmann, S. | | Deposit date: | 2024-02-12 | | Release date: | 2024-05-22 | | Last modified: | 2024-06-05 | | Method: | X-RAY DIFFRACTION (1.836 Å) | | Cite: | Ligandability Assessment of IL-1 beta by Integrated Hit Identification Approaches.
J.Med.Chem., 67, 2024
|
|
5BOW
 | | CRYSTAL STRUCTURE OF IL-38 | | Descriptor: | 1,2-ETHANEDIOL, Interleukin-1 family member 10 | | Authors: | Guenther, S, Sundberg, E.J. | | Deposit date: | 2015-05-27 | | Release date: | 2016-06-01 | | Last modified: | 2017-11-22 | | Method: | X-RAY DIFFRACTION (1.31 Å) | | Cite: | Crystal Structure of Interleukin-38
To Be Published
|
|
6HPI
 | |
5BVP
 | |
8Q3J
 | | Crystal structure of mIL-38 in complex with a neutralizing Fab e04 fragment | | Descriptor: | Fab e04 Heavy Chain (e04 HC), Fab e04 Light Chain (e04 LC), Interleukin-1 family member 10, ... | | Authors: | Garcia-Pardo, J, Da Silva, P, Mora, J, Wiechmann, S, Putyrski, M, You, X, Kannt, A, Ernst, A, Brune, B, Weigert, A. | | Deposit date: | 2023-08-04 | | Release date: | 2024-08-14 | | Last modified: | 2024-09-11 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Neutralizing IL-38 activates gamma delta T cell-dependent antitumor immunity and sensitizes for chemotherapy.
J Immunother Cancer, 12, 2024
|
|
4R6U
 | | IL-18 receptor complex | | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Interleukin-18, Interleukin-18 receptor 1 | | Authors: | Wei, H, Wang, X. | | Deposit date: | 2014-08-26 | | Release date: | 2014-10-15 | | Last modified: | 2023-09-20 | | Method: | X-RAY DIFFRACTION (2.8 Å) | | Cite: | Structural basis for the specific recognition of IL-18 by its alpha receptor.
Febs Lett., 588, 2014
|
|
